Clinical Trials Browser

Phase 2 × palbociclib × Tumor-Agnostic × Clear all

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

Phase 2 Unknown

Neoplasms

NCT03123744 2018-06-21

Histology-Independent Study of Palbociclib in Patients With Advanced Cancer

Phase 2 Withdrawn

Neoplasms